Uniqure provides regulatory update on amt-130 for huntington's disease

~ alignment with fda continues to support accelerated approval pathway ~ ~ bla submission planned for first quarter of 2026 ~ ~ conference call today at 8:30 a.m. et ~ lexington, mass.
AMT Ratings Summary
AMT Quant Ranking